Starlix and Lipase increased - a phase IV clinical study of FDA data

Summary:

Lipase increased is found among people who take Starlix, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Starlix and have Lipase increased. It is created by eHealthMe based on reports of 3,716 people who have side effects when taking Starlix from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

3,716 people reported to have side effects when taking Starlix.
Among them, 6 people (0.16%) have Lipase increased.

What is Starlix?

Starlix has active ingredients of nateglinide. It is often used in diabetes. eHealthMe is studying from 3,758 Starlix users for its effectiveness, alternative drugs and more.

What is Lipase increased?

Lipase increased is found to be associated with 1,713 drugs and 1,001 conditions by eHealthMe.

Number of Starlix and Lipase increased reports submitted per year:

Gender of people who have Lipase increased when taking Starlix *:

female: 80 %
male: 20 %

Age of people who have Lipase increased when taking Starlix *:

Common drugs people take besides Starlix *:

Common side effects people have besides Lipase increased *:

Blood Glucose Increased: 3 people, 50.00%
White Blood Cell Count Increased: 2 people, 33.33%
Weight Decreased: 2 people, 33.33%
Pancreatitis (inflammation of pancreas): 2 people, 33.33%
Liver Function Test Abnormal: 2 people, 33.33%
Diarrhea: 2 people, 33.33%
Dehydration (dryness resulting from the removal of water): 2 people, 33.33%
Glycosylated Haemoglobin Increased: 1 person, 16.67%
Duodenitis (inflammation of the duodenum): 1 person, 16.67%
Drug Ineffective: 1 person, 16.67%

Common conditions people have *:

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 33.33%
Osteoporosis (bones weak and more likely to break): 1 person, 16.67%
High Blood Pressure: 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Starlix and have Lipase increased?

Check whether Lipase increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Lipase increased and when was it recovered:

Lipase increased in Starlix

Expand to all the drugs that have ingredients of nateglinide:

Lipase increased and drugs with ingredients of nateglinide (8 reports)

Alternative drugs to, pros and cons of Starlix:

Starlix (3,758 reports)

Common Starlix side effects:

Browse all side effects of Starlix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lipase increased treatments and more:

Lipase increased (10,687 reports)

COVID vaccines that are related to Lipase increased:

Common drugs associated with Lipase increased:

All the drugs that are associated with Lipase increased:

Lipase increased (1,713 drugs)

Common conditions associated with Lipase increased:

Type 2 diabetes: 769 reports
High blood pressure: 617 reports
Diabetes: 394 reports
Hiv infection: 293 reports

All the conditions that are associated with Lipase increased:

Lipase increased (1,001 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nateglinide (the active ingredients of Starlix) and Starlix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.